We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics: challenges of assessment in biological samples and their implication for in vitro and in vivo effects
Summary
This review covers how microplastics enter the human body through ingestion and inhalation, the challenges of detecting and measuring them in biological samples, and the evidence for harmful effects ranging from inflammation to hormonal disruption. Standardising methods for measuring microplastics in tissues and bodily fluids is a key obstacle to advancing human health research. The review provides a useful framework for understanding what we know and what still needs to be established about microplastic risks to people.
Abstract Microplastics (MPs) have attracted global interest because they have been recognized as emerging pollutants that require urgent attention. MPs are plastic particles with a size between 1 micron and 5 millimeters (1 µm-5mm); those measuring less than 1 µm are known as nanoplastics (NPs). MPs are distributed in the environment in various physical forms that depend on the original morphology of the primary plastics, the degradation process, and the erosion factors to which they were subjected. Humans may be exposed to these pollutants mainly by ingestion or inhalation, which could adversely affect human health. This review focuses on exposure pathways, sources, and evidence of adverse effects reported in vitro and in vivo studies. In addition , we highlight the application of methods and techniques to assess the precise levels of exposure to MPs in biological samples to generate knowledge about their potential threat to human health.
Sign in to start a discussion.